{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Athens",
      "state": "OH",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "83074",
      "recalling_firm": "RXQ Compounding LLC",
      "address_1": "340 W State St Unit 9",
      "address_2": "N/A",
      "postal_code": "45701-1564",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide USA",
      "recall_number": "D-1634-2019",
      "product_description": "Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0173-10",
      "product_quantity": "N/A",
      "reason_for_recall": "Crystallization",
      "recall_initiation_date": "20190619",
      "center_classification_date": "20190808",
      "termination_date": "20220916",
      "report_date": "20190814",
      "code_info": "All lots within expiry"
    }
  ]
}